Ligartis GmbH

1 clinical trials · Sponsor

Record	Firm	Date
Phase Ib/II Study Assessing the Neo-adjuvant Combination Therapy of Vinflunine With Cisplatin Followed by Radical Cystectomy in Patients With Muscle-invasive Bladder Cancer (JaNEO) (NCT02845050)	Ligartis GmbH	2016-07-01

Every clearance here is in the API, with alerts when new ones post.